Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Aug 9, 2018 · 10-Q · 40 days after period end · 0001615774-18-007805
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$2.85M | -$3.61M | -$2.24M | -$4.24M |
| EPS Diluted | -$0.06 | -$0.04 | -$0.06 | -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 9, 2018 · 40 d after period end
